Novel Method for Mass Production of Recombinant Proteins Using MSG
On 30th May, 2024, researchers at the Indian Institute of Science (IISc) unveiled a novel method to mass produce recombinant proteins, including vaccine antigens and insulin, replacing hazardous methanol with mono-sodium glutamate (MSG).
- The new expression system aims to produce proteins for biotech industries, including milk and egg proteins, baby food supplements, nutraceuticals, and therapeutic molecules.
- An Indian patent has been granted, and a US patent has been filed for the novel expression system, with plans to collaborate with industry partners for scaling up production.
- The conventional method involves using methanol to activate yeast cells, which poses significant safety risks due to its ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Kisan Kavach Suit
- 2 Hybrid Aerogel for Gold Extraction from E-Waste
- 3 New Breakthrough in Haemophilia Treatment
- 4 Cellular-Level Map of Growing Foetal Brains
- 5 India’s Zorawar Light Tank Hits Major Milestone
- 6 CE20 Cryogenic Engine: ISRO Achieves Major Milestone
- 7 Japan-India Collaboration on Space Debris Removal
- 8 IIT Bombay Unveils AroTrack
- 9 ‘One Day One Genome’ Initiative Unveiled
- 10 New Technology Enhances HIV Genome Detection
- 1 ISRO and CNES Collaborate on TRISHNA Mission
- 2 ISRO Develops “PraVaHa” CFD Software
- 3 NASA to Expand Collaboration with India
- 4 RudraM-II Missile
- 5 Chlorella Growth Factor (CGF)
- 6 New AI Model Predicts El Niño and La Niña 15 Months in Advance
- 7 Quantum Diamond Microchip Imager
- 8 Indian Army and IOCL Partner for Green Transport Solutions
